Home Obi Profile Fees Services News Publications Contact  
You are here: Title Details
Search  
    Login
Inventions Industrial DesignTechnological Information
ORAL IMMEDIATE RELEASE FORMULATIONS FOR SUBSTITUTED QUINAZOLINONES

No-Receipt date 2019-03254 - 27/08/2019
No-Filing date 20190402614 - 27/08/2019
No-Granting date 3101024 - 14/10/2019
No-EPO application date 12844794.3 - 31/10/2012
No-EPO granting date 2773354 - 12/06/2019
Gazette No-Publication date of application -
Gazette No-Publication date of granted patent 10/2019 - 28/11/2019
Expiration date 01/11/2032
Kind of title Validation of European Patent
Legal status VALID
Priorities US201161554090 P01/11/2011/US
Active Substance of Supplementary Certificates -

IPC Classification
Ipc Class
A61K 31/517
A61K 9/48

Related Documents

Related Titles

Owners
CodeFirstnameSurnameAddressTownZIPCountry
1055930 RESVERLOGIX CORP. 300, 4820 RICHARD ROAD SWCALGARY, AB T3E 6L1 CANADA

Inventors
CodeFirstnameSurname
2660656 SHENOY, NARMADA, R.

Representatives
CodeFirstnameSurnameAddressTownZip
3463MARIAATHANASIADOU "ELENI G. PAPAKONSTANTINOU KAI SYNERGATES, DIKIGORIKI ETAIRIA"KOUMPARI 2ATHINA (ATTIKIS)10674

Contact
CodeFirstnameSurnameAddressTownZipCountry
848EFANGELIAGIAZITZOGLOU - THOMAIDOUKOUMPARI 2ATHINA (ATTIKIS)10674 GREECE

Owners History

Title Instruments

Payments history 13 renewals have been done
Print
Dues Online PaymentNational Patent RegisterOne Stop Shop (OSS)
© OBI all rights reserved designed & developed by PROFILE S.A.
Certified QMS : EN ISO 9001:2015 and ΕΝ ISO 14001:2015